Bringing new players into the field: onco-pharmacovigilance in the era of cardio-oncology

被引:10
作者
Albini, Adriana [1 ,2 ]
Donatelli, Francesco [3 ,4 ,5 ]
Noonan, Douglas [1 ,6 ]
D'Elios, Mario Milco [7 ]
Prisco, Domenico [7 ]
机构
[1] Polo Sci & Tecnol PST IRCCS MultiMed, Oncol Res Div, Milan, Italy
[2] MultiMedica, Castellanza, VA, Italy
[3] IRCCS MultiMed, Dept Cardiovasc & Metab Dis, Milan, Italy
[4] San Giuseppe Hosp, Milan, Italy
[5] Univ Milan, Dept Cardiothorac Surg, Milan, Italy
[6] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy
[7] Univ Florence, Patol Med AOU Careggi Hosp, Florence, Italy
关键词
CARDIOTOXICITY;
D O I
10.1007/s11739-012-0756-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:99 / 101
页数:3
相关论文
共 8 条
[1]  
Albini A, 2011, FUTUR CARDIOL, V7, P693, DOI [10.2217/fca.11.54, 10.2217/FCA.11.54]
[2]   Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention [J].
Albini, Adriana ;
Pennesi, Giuseppina ;
Donatelli, Francesco ;
Cammarota, Rosaria ;
De Flora, Silvio ;
Noonan, Douglas M. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (01) :14-25
[3]   Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition [J].
Cardinale, Daniela ;
Colombo, Alessandro ;
Sandri, Maria T. ;
Lamantia, Giuseppina ;
Colombo, Nicola ;
Civelli, Maurizio ;
Martinelli, Giovanni ;
Veglia, Fabrizio ;
Fiorentini, Cesare ;
Cipolla, Carlo M. .
CIRCULATION, 2006, 114 (23) :2474-2481
[4]   Biochemical Markers for Prediction of Chemotherapy-Induced Cardiotoxicity Systematic Review of the Literature and Recommendations for Use [J].
Dolci, Alberto ;
Dominici, Roberto ;
Cardinale, Daniela ;
Sandri, Maria T. ;
Panteghini, Mauro .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (05) :688-695
[5]   Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology [J].
Raschi, Emanuel ;
De Ponti, Fabrizio .
INTERNAL AND EMERGENCY MEDICINE, 2012, 7 (02) :113-131
[6]   Reporting of Serious Adverse Drug Reactions of Targeted Anticancer Agents in Pivotal Phase III Clinical Trials [J].
Seruga, Bostjan ;
Sterling, Lynn ;
Wang, Lisa ;
Tannock, Ian F. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) :174-185
[7]  
Siragusa S, 2011, THROMB RES
[8]   Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort [J].
Veglio, M ;
Bruno, G ;
Borra, M ;
Macchia, G ;
Bargero, G ;
D'Errico, N ;
Pagano, GF ;
Cavallo-Perin, P .
JOURNAL OF INTERNAL MEDICINE, 2002, 251 (04) :317-324